|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research and Practice |
1 Harvard Medical School/Cambridge Health Alliance
* To whom correspondence should be addressed. E-mail: scutrona{at}hsph.harvard.edu.
| Abstract |
|---|
Objectives. Free prescription drug samples are used widely in the United States. We sought to examine characteristics of free drug sample recipients nationwide.
Methods. We analyzed data on 32 681 US residents from the 2003 Medical Expenditure Panel Survey (MEPS), a nationally representative survey.
Results. In 2003, 12% of Americans received at least 1 free sample. A higher proportion of persons who had continuous health insurance received a free sample (12.9%) than did persons who were uninsured for part or all of the year (9.9%; P <.001). The poorest third of respondents were less likely to receive free samples than were those with incomes at 400% of the federal poverty level or higher. After we controlled for demographic factors, we found that neither insurance status nor income were predictors of the receipt of drug samples. Persons who were uninsured all or part of the year were no more likely to receive free samples (odds ratio [OR]=0.98; 95% confidence interval [CI]=0.087, 1.11) than were those continuously insured.
Conclusions. Poor and uninsured Americans are less likely than are wealthy or insured Americans to receive free drug samples.
Key Words: Community Health, Health Policy, Access to Care
This article has been cited by other articles:
![]() |
S. L. Cutrona, S. Woolhandler, K. E. Lasser, D. H. Bor, D. U. Himmelstein, W. H. Shrank, and N. S. LeLeiko Free Drug Samples in the United States: Characteristics of Pediatric Recipients and Safety Concerns Pediatrics, October 1, 2008; 122(4): 736 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Vincent, A. M. Wiesner, and D. T. Steinke "FREE" PRESCRIPTION DRUG SAMPLES ARE NOT FREE Am J Public Health, August 1, 2008; 98(8): 1348 - 1349. [Full Text] [PDF] |
||||
![]() |
S. L. Cutrona, S. Woolhandler, K. E. Lasser, D. H. Bor, D. McCormick, and D. U. Himmelstein CUTRONA ET AL. RESPOND Am J Public Health, August 1, 2008; 98(8): 1349 - 1349. [Full Text] [PDF] |
||||
![]() |
Drug Samples: Marketing Tool or Safety Net? Journal Watch (General), February 14, 2008; 2008(214): 1 - 1. [Full Text] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |